Live from the NIH registry
Studies recruiting near Akron right now
Top 25 of 394 recruiting studies, sorted by proximity — each links to its official registry page
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Carcinoma, Non-small-Cell Lung
Phase 2
Interventional 520 participants sought
Cleveland Clinic 3 — Warrensville Heights, Ohio (24.6 mi)
· Sponsor: Janssen Research & Development, LLC
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,000 participants sought
Research Site — Canton, Ohio (20.8 mi)
· Sponsor: AstraZeneca
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
Major Depressive Disorder (MDD), Major Depressive Disorder With Anxious Distress
Phase 2
Interventional 360 participants sought
Seaport Investigator Site — North Canton, Ohio (15.4 mi)
· Sponsor: Seaport Therapeutics
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 800 participants sought
Cleveland Clinic Akron General — Akron, Ohio (0.2 mi)
· Sponsor: Eli Lilly and Company
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 3
Interventional 5,951 participants sought
Children's Hospital Medical Center of Akron — Akron, Ohio (0.2 mi)
· Sponsor: Children's Oncology Group
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Cleveland Clinic Akron General — Akron, Ohio (0.2 mi)
· Sponsor: NRG Oncology
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Yanke Bionics - W Exchange St — Akron, Ohio (0.2 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
University Hospitals Parma Medical Center — Parma, Ohio (24.8 mi)
· Sponsor: NRG Oncology
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Narcolepsy Type 1, Narcolepsy Type 2
Phase 2, Phase 3
Interventional 786 participants sought
Alkermes Investigational Site — Canton, Ohio (20.8 mi)
· Sponsor: Alkermes, Inc.
A Study of T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC
Nonmuscle-invasive Bladder Cancer
Phase 2
Interventional 160 participants sought
Helios Clinical Research — Middleburg Heights, Ohio (24.6 mi)
· Sponsor: ImmVira Pharma Co. Ltd
Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia
Tardive Dyskinesia
Phase 2
Interventional 100 participants sought
Neurocrine Clinical Site — Beachwood, Ohio (26.6 mi)
· Sponsor: Neurocrine Biosciences
Yoga for Black and Brown Women Who Have Experienced Abuse From an Intimate Partner
Intimate Partner Violence (IPV), Psychological Well Being
Phase 1
Interventional 40 participants sought
the University of Akron — Akron, Ohio (0.2 mi)
· Sponsor: The University of Akron
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
Diabetic Retinopathy
Phase 2, Phase 3
Interventional 576 participants sought
Retina Associates Of Cleveland - Beachwood /ID# 275985 — Beachwood, Ohio (26.6 mi)
· Sponsor: AbbVie
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Cleveland Clinic Mercy Hospital — Canton, Ohio (20.8 mi)
· Sponsor: SWOG Cancer Research Network
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,900 participants sought
Summa Health System - Akron Campus — Akron, Ohio (0.2 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
Pneumonia
N/A
Observational 12,500 participants sought
Summa Health Clinical Research Center - Specialty — Akron, Ohio (0.2 mi)
· Sponsor: Pfizer
International Rare Brain Tumor Registry
Astroblastoma, BCOR ITD Sarcoma
N/A
Observational 5,800 participants sought
Akron Children's Hospital — Akron, Ohio (0.2 mi)
· Sponsor: Children's National Research Institute
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Atopic Dermatitis (AD)
Phase 2
Interventional 105 participants sought
Enveda Investigative Site — Canton, Ohio (20.8 mi)
· Sponsor: Enveda Therapeutics
A Study of Cebranopadol for Opioid Withdrawal Symptoms in Adults With Chronic Pain
Chronic Pain, Pain
Phase 2
Interventional 45 participants sought
001127 — North Canton, Ohio (15.4 mi)
· Sponsor: Adneuris Therapeutics, Inc.
The PREDICT Registry:
DCIS, Stage 0 Breast Cancer
N/A
Observational 3,000 participants sought
Cleveland Clinic Akron General — Akron, Ohio (0.2 mi)
· Sponsor: PreludeDx
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Solid Tumor, Adult, Metastatic Solid Tumor
Phase 1
Interventional 130 participants sought
Gabrail Cancer & Research Center — Canton, Ohio (20.8 mi)
· Sponsor: Sairopa B.V.
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
Plasma Cell Myeloma Refractory
Phase 2
Interventional 64 participants sought
Gabrail Cancer Center- Site Number : 8400010 — Canton, Ohio (20.8 mi)
· Sponsor: Sanofi
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 1,100 participants sought
Velocity Clinical Research - Cleveland — Beachwood, Ohio (26.6 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Psoriatic Arthritis
Phase 3
Interventional 1,088 participants sought
Paramount Medical Research & Consulting, LLC — Middleburg Heights, Ohio (24.6 mi)
· Sponsor: Takeda
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Non-alcoholic Fatty Liver Disease
Phase 3
Interventional 1,250 participants sought
GSK Investigational Site — Akron, Ohio (0.2 mi)
· Sponsor: GlaxoSmithKline